Company: CMND
Filing Date: 2025-11-19
Form Type: 424B5
Source: 0001213900-25-112329
Chunk: 59

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-19
Form: 424B5
Chunk 59
---
 ● | the trading price of the warrants; |

| ● | the price of the underlying securities at that time; |

| ● | the time remaining to expiration; and |

| ● | any related transaction costs. |

Some of the factors referred
to above are in turn influenced by various political, economic and other factors that can affect the trading price of the underlying securities
and should be carefully considered prior to making any investment decisions.

Purchasers of the warrants
should further consider that the initial offering price of the warrants may be in excess of the price that a purchaser of options might
pay for a comparable option in a private, less liquid transaction. In addition, it is not possible to predict the price at which the warrants
will trade in the secondary market or whether any such market will be liquid. We may, but will not be obligated to, file an application
to list any warrants on a U.S. national securities exchange. To the extent that any warrants are exercised, the number of warrants outstanding
will decrease, which may result in a lessening of the liquidity of the warrants. Finally, the warrants will constitute our direct, unconditional
and unsecured obligations and, as such, will be subject to any changes in our perceived creditworthiness.

Exercise of Warrants

Each holder of a warrant will
be entitled to purchase that number or amount of underlying securities, at the exercise price, as will in each case be described in the
prospectus supplement relating to the offered warrants. After the close of business on the Expiration Date (which may be extended by us),
unexercised warrants will become void.

Holders may exercise warrants
by delivering to the warrant agent payment as provided in the applicable prospectus supplement of the amount required to purchase the
underlying securities purchasable upon exercise, together with the information set forth on the reverse side of the warrant certificate.
Warrants will be deemed to have been exercised upon receipt of payment of the exercise price, subject to the receipt within two (2) business
days of the warrant certificate evidencing the exercised warrants. Upon receipt of payment and the warrant certificate properly completed
and duly executed at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement,
we will, as soon as practicable, issue and deliver the underlying securities purchasable upon such exercise. If fewer than all of the
warrants represented by a warrant certificate are exercised, we will issue a new warrant certificate for the remaining amount of warrants.